TENTH OF RAMADAN FOR PHARMACEUTICAL INDUSTRIES AND DIAGNOSTIC REAGENTS (RAMEDA) S.A.E. Consensus Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
Equities
RMDA
EGS381B1C015
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.3 EGP | -0.43% |
|
-0.86% | +39.39% |
Evolution of the average Target Price on Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
Price target over the last 5 years
History of analyst recommendation changes
2.gBTi8IXOm1o_fwHteqNxvPLqxxcoPYIQJQ3loUzoa00.s0DTvuGXqxJHPDHbHJUQ2rWCkW4fS-l5aGijlAipHHX0UZq-9qzuCFAzYg~7d4cc6c9bb9206cf6132beb9ddcb361a
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.3
EGP
Average target price
4.41
EGP
Spread / Average Target
+91.74%
High Price Target
5.7
EGP
Spread / Highest target
+147.83%
Low Price Target
3.58
EGP
Spread / Lowest Target
+55.65%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RMDA Stock
- Consensus Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
